| Fusion polypeptides for genetic editing and methods of use thereof |
2022-9-27 |
2023-3-30 |
|
| Compositions and methods for multiplex base editing in hematopoietic cells |
2022-9-14 |
2023-3-23 |
|
| Compositions and methods for gene modification |
2022-8-02 |
2023-2-09 |
|
| Chimeric antigen receptors for treatment of cancer |
2022-7-29 |
2023-2-02 |
|
| Nfat-responsive reporter systems for assessing chimeric antigen receptor … |
2022-7-29 |
2023-2-02 |
|
| Inhibitor oligonucleotides for crispr/cas gene editing and methods of use … |
2022-7-06 |
2023-2-16 |
|
| Genetically engineered hematopoietic stem cells and uses thereof |
2022-5-31 |
2023-2-16 |
|
| Photocleavable guide rnas and methods of use thereof |
2022-4-08 |
2022-10-13 |
|
| Compositions and methods for cd123 modification |
2022-2-23 |
2022-4-01 |
|
| Compositions and methods for cll1 modification |
2022-2-23 |
2022-4-01 |
|
| Compositions and methods for cd34 gene modification |
2021-12-31 |
2022-7-07 |
|
| Methods and compositions relating to genetically engineered cells expressing … |
2021-11-12 |
2022-5-19 |
|
| Compositions and methods for bcma modification |
2021-10-29 |
2022-5-05 |
|
| Compositions and methods for treating hematopoietic malignancy |
2021-10-27 |
2022-5-05 |
|
| Chimeric antigen receptor expression systems |
2021-9-30 |
2022-4-07 |
|
| Compositions and methods for cd30 gene modification |
2021-9-30 |
2022-4-07 |
|
| Compositions and methods for cd6 modification |
2021-9-28 |
2022-3-31 |
|
| Compositions and methods for cd7 modification |
2021-9-17 |
2022-3-24 |
|
| Compositions and methods for cd5 modification |
2021-9-14 |
2022-3-17 |
|
| Chimeric antigen receptors for treatment of cancer |
2021-9-14 |
2022-3-17 |
|
| Compositions and methods for cd38 modification |
2021-9-14 |
2022-3-17 |
|
| Single domain antibodies against cd33 |
2021-9-14 |
2022-3-17 |
|
| Single domain antibodies against cd33 |
2021-9-14 |
2022-3-17 |
|
| Compositions and methods for cll1 modification |
2021-8-27 |
2022-3-03 |
|
| Compositions and methods for cd123 modification |
2021-8-27 |
2022-3-03 |
|
| Compositions and methods for CD33 modification |
2020-5-22 |
2022-4-29 |
|
| Compositions and methods for inhibition of lineage specific proteins |
2019-8-25 |
2019-10-31 |
|
| Anticorps a domaine unique anti-cd33 |
2021-9-14 |
2022-3-17 |
|